Showing results (221-230 of 257) with videos related to

Sort By:
Pageof 26
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 3, 2001
T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancerH W Nijman, P J van Diest, R J Poort-Keesom, et al.
Fertility and Sterility|February 6, 2003
A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levelsR G V Smolders, M J van der Mooren, T Teerlink, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 28, 2001
Survival analysis in familial ovarian cancer, a case control studyR P Zweemer, R H Verheijen, J W Coebergh, et al.
International Journal of Cancer|January 21, 1991
Carcinoma-associated mucin serum markers CA M26 and CA M29: efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervixK A Yedema, P Kenemans, T Wobbes, et al.
Lancet (London, England)|July 16, 1999
Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective studyM A Nobbenhuis, J M Walboomers, T J Helmerhorst, et al.
The Journal of Experimental Medicine|July 1, 1995
Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cellsH W Nijman, M J Kleijmeer, M A Ossevoort, et al.
Breast (Edinburgh, Scotland)|December 6, 2007
Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trialP Kenemans, E Kubista, J M Foidart, et al.
Journal of the National Cancer Institute|August 16, 1995
Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinomaM A Izquierdo, A G van der Zee, J B Vermorken, et al.
The Journal of Experimental Medicine|August 29, 1997
Tumor eradication by wild-type p53-specific cytotoxic T lymphocytesM P Vierboom, H W Nijman, R Offringa, et al.
European Journal of Immunology|September 1, 1993
In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53J G Houbiers, H W Nijman, S H van der Burg, et al.
Pageof 26